Abbott Comprehensive Ethics and Compliance Program
Abbott Comprehensive Ethics and Compliance Program
Abbott Comprehensive Ethics and Compliance Program
Introduction
The Investors section of Abbott Laboratories’ website (http://www.abbott.com) conveys the essence of
Abbott’s ethics and compliance program (the “Program”). Abbott’s Program reflects Abbott’s
commitment to compliance with the laws and regulations applicable to our business, including the
California Health and Safety Code §§119400-119402 (the “California Act”). This document describes the
fundamental elements of Abbott’s Program. The reader is also encouraged to review the Abbott Code of
Business Conduct (“Abbott Code”) in the Investors - Governance section of Abbott’s website.
Interested parties may also call 1-855-294-4584 to request a copy of this document or any of the above-
referenced materials.
Program
Abbott’s Program is an integrated, company-wide program that is based on company values, laws and
regulations. It is organized around the seven elements of an effective compliance program as set forth in
the voluntary “Compliance Program Guidance for Pharmaceutical Manufacturers” published in April
2003 by the Office of Inspector General, U.S. Department of Health and Human Service (“HHS-OIG
Guidance”). The program also requires compliance with voluntary industry guidelines, including the
Advanced Medical Technology Association Code of Ethics on Interactions with Health Care Professionals
(“AdvaMed Code”), which was most recently revised as of January 2020. Following is a brief description
of each of the seven elements of Abbott’s Program.
1. Leadership
The Chief Ethics and Compliance Officer (CECO) is responsible for the management and operation of the
Office of Ethics and Compliance (OEC) and the development and enhancement of the compliance
program. The CECO makes regular reports regarding compliance matters to the Chairman of the Board
and the Chief Executive Officer, senior level leadership and Abbott’s Board of Directors and committees.
The Business Conduct Committee (BCC) consists of senior-level leadership and is chaired by the CECO.
The BCC is accountable directly to the Chairman of the Board and the Chief Executive Officer and was
established to assist in the implementation of the compliance program. The BCC holds periodic meetings
to discuss matters including: 1. the legal and regulatory environment, risk areas and best practices; and
2. modifications to the compliance program on the basis of such evaluation. OEC staff provides
dedicated support to each of Abbott’s businesses.
2. Written Standards
Our basic guidelines and requirements for ethical behavior are set forth in the Abbott Code of Business
Conduct, published in print and online in 29 languages. Abbott employees read and certify adherence to
our Code annually. Our Code states clearly that Abbott does not tolerate illegal or unethical behavior in
any aspect of our business. It emphasizes the importance of ethical and honest conduct, adhering to
Abbott’s policies and procedures, treating confidential information appropriately, avoiding conflicts of
interest and maintaining Abbott’s books and records with accuracy and integrity. Further, it requires our
employees to ask questions or report any concerns.
In addition to our Code, we adopt policies and procedures that guide employees as they conduct their
day-to-day activities. They encompass relevant laws and regulations, including food and drug laws and
laws relating to government health care programs. They also take into account industry best practices,
including provisions of the updated Advanced Medical Technology Association (AdvaMed) Code of Ethics
on Interactions with Health Care Professionals, as well as other applicable industry codes. We regularly
update our policies to incorporate changes to the law and industry codes, including rules regarding gifts,
meals and education we provide to health care professionals.
All allegations reported to the OEC Investigations Group are investigated and documented. Specifically,
once an allegation is received, an assigned investigator is tasked with examining the allegations and a
report is sent to a Director, or more senior member of the OEC, for review to ensure consistency and
completeness. Where necessary, the OEC then works with management and human resources to
implement corrective action, which can range from counseling and coaching to termination.
4. Training
Training and education programs for employees increase their awareness of our Code’s precepts and
the legal and ethical implications of their actions and behaviors. Abbott ethics and compliance officers
work with our local commercial teams throughout the world to help them conduct trainings and
education programs that help ensure compliance and strengthen Abbott’s reputation as a responsible
corporate citizen while enhancing relationships with customers and other stakeholders.
For example, employees in more than 80 countries, including the U.S., Puerto Rico, Latin America,
Europe, and Asia, participate in our Legal and Ethics Resource Network program, a Web-based training
system designed to increase awareness of the legal and ethical implications of business decisions. There
are also many live, in person training sessions on specific topics.
5. Accountability
Abbott employees are expected to adhere to our Code as a condition of their continued employment.
Any Abbott employee who violates our Code, or any policy or procedure, is subject to appropriate
disciplinary action. Any Abbott employee who fails to report a violation of Abbott policy or procedure of
which he/she is, or should have been, aware may also be subject to disciplinary action. Abbott does not
tolerate retaliation against anyone who makes a good-faith report regarding a violation or potential
violation of our Code, policies or procedures. These guidelines are well publicized and enforced.
6. Assessment
The OEC utilizes results from internal investigations, internal audits and internal monitoring programs to
assess the effectiveness of, and identify areas for improvement in, the compliance program and relevant
business practices. In addition, we consider the external environment, including government
investigations, settlements, industry codes and government guidance to identify new opportunities to
enhance the compliance program.
7. Remediation
Results of investigations, audits and monitoring are communicated to the appropriate OEC staff and
business leaders. When an area for improvement is identified, the OEC partners with the business to
implement corrective actions.